• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Predictive Oncology Inc. - Common Stock (NQ:POAI)

    0.9338 -0.0162 (-1.71%)
    Streaming Delayed Price Updated: 12:50 PM EDT, Jun 6, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 18,045
    Open 0.9600
    Bid (Size) 0.9302 (2)
    Ask (Size) 0.9500 (9)
    Prev. Close 0.9500
    Today's Range 0.9202 - 0.9600
    52wk Range 0.5500 - 3.060
    Shares Outstanding 4,063,081
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Court Denies Renovaro Motion for an Expedited Trial in July
    From Predictive Oncology Inc.
    Via GlobeNewswire
    Predictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans Bullish
    Renovaro said the Delaware Court of Chancery had approved an expedited trial schedule for the lawsuit it filed to enforce a binding merger agreement with Predictive Oncology. 
    Via Stocktwits
    Topics Artificial Intelligence Lawsuit
    Exposures Artificial Intelligence Financial Legal

    Performance

    YTD
    +1.5%
    +1.5%
    1 Month
    -9.3%
    -9.3%
    3 Month
    -25.3%
    -25.3%
    6 Month
    +23.6%
    +23.6%
    1 Year
    -33.8%
    -33.8%

    More News

    Read More
    UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
    From Renovaro Inc
    Via GlobeNewswire
    Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
    From Renovaro Inc
    Via GlobeNewswire
    AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
    From Predictive Oncology Inc.
    Via GlobeNewswire
    Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
    From Predictive Oncology Inc.
    Via GlobeNewswire
    Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
    From Predictive Oncology Inc.
    Via GlobeNewswire
    Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
    From FN Media Group LLC
    Via GlobeNewswire
    Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs
    From Predictive Oncology Inc.
    Via GlobeNewswire
    Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
    From FN Media Group LLC
    Via GlobeNewswire
    Renovaro Provides Update to Definitive Agreement with Predictive Oncology
    From Renovaro Inc
    Via GlobeNewswire
    Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
    From Predictive Oncology Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Breakthroughs and Discoveries: TNON, PNPN.V, POAI, DYAI, PRSO, Drive Innovation Across Sectors
    Via AB Newswire
    Topics Artificial Intelligence
    Exposures Artificial Intelligence Product Safety
    Top movers analysis one hour before the close of the markets on 2025-03-25: top gainers and losers in today's session.
    Via Chartmill
    Discover the most active stocks in Tuesday's session.
    Via Chartmill
    Which stocks are experiencing notable movement on Tuesday?
    Via Chartmill
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Let's uncover which stocks are experiencing notable gaps during today's session.
    Via Chartmill
    What's Going On With Predictive Oncology Shares Tuesday?
    Via Benzinga
    Which stocks are moving before the opening bell on Tuesday?
    Via Chartmill
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga

    Frequently Asked Questions

    Is Predictive Oncology Inc. - Common Stock publicly traded?
    Yes, Predictive Oncology Inc. - Common Stock is publicly traded.
    What exchange does Predictive Oncology Inc. - Common Stock trade on?
    Predictive Oncology Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Predictive Oncology Inc. - Common Stock?
    The ticker symbol for Predictive Oncology Inc. - Common Stock is POAI on the Nasdaq Stock Market
    What is the current price of Predictive Oncology Inc. - Common Stock?
    The current price of Predictive Oncology Inc. - Common Stock is 0.9338
    When was Predictive Oncology Inc. - Common Stock last traded?
    The last trade of Predictive Oncology Inc. - Common Stock was at 06/06/25 12:50 PM ET
    What is the market capitalization of Predictive Oncology Inc. - Common Stock?
    The market capitalization of Predictive Oncology Inc. - Common Stock is 3.79M
    How many shares of Predictive Oncology Inc. - Common Stock are outstanding?
    Predictive Oncology Inc. - Common Stock has 4M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.